Some research suggests supplements such as berberine, curcumin, resveratrol, fish oil, and probiotics may boost your body's ...

You’re reading The Checkup With Dr. Wen, a newsletter on how to navigate medical and public health challenges. Click here to ...

Constipation is a common but manageable side effect of Ozempic, a medication for diabetes and weight loss. It often occurs in ...

Patients with type 2 diabetes who use GLP-1 receptor agonists have a significantly lower risk for lung cancer than those who ...

DexCom's growth rate has been improving, but that hasn't been enough of a reason for investors to buy up the stock.

ATLANTA -- Women who had been taking GLP-1 receptor agonist medications prior to becoming pregnant had a lower risk of gestational diabetes but not pre-eclampsia during pregnancy, according to a small ...

The growing burden of chronic kidney disease (CKD) and end-stage renal disease (ESRD) has been a major driver of demand for dialysis and kidney transplantation for decades. CKD is a progressive loss ...

This product is a 2025 Women's Health Skincare Award Winner for a reason. It helps hydrate the lips to provide extra plump.

In the new era of tell-all beauty, weight-loss injections — better known as GLP-1s like Ozempic, Mounjaro, Zepbound, and ...

Eli Lilly and Novo Nordisk’s competition in weight-loss drugs has affected thousands of jobs between Charlotte and Raleigh. Who is winning?

Novo Nordisk (NVO) is deeply undervalued after a 43% YTD decline, despite strong fundamentals and global obesity market ...

Wall St. provides estimates for future stock prices of Eli Lilly from 2025 to 2030 based on projected revenue and net income.